# Inovio Pharmaceuticals (INO) — News

INO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ino/news

## Recent headlines

- [Monkeypox stocks fell in intraday trading, with INO down 9.0%, TNXP falling 3.5% and VRAX sliding 2.7%.](https://www.ainvest.com/news/monkeypox-stocks-fell-intraday-trading-ino-9-0-tnxp-falling-3-5-vrax-sliding-2-7-2610-52) — AInvest Wire, Oct 13, 2026
- [Inovio 2Q R&D expenses $10.8M vs $14.5M Y/Y](https://www.ainvest.com/news/inovio-2q-expenses-10-8m-14-5m-2608) — AInvest Wire, Aug 12, 2026
- [Inovio 2Q loss/share 7.0c vs. loss/share 61c y/y](https://www.ainvest.com/news/inovio-2q-loss-share-7-0c-loss-share-61c-2608) — AInvest Wire, Aug 12, 2026
  INOVIO Pharmaceuticals, Inc. (NASDAQ: INO) reported a net loss of $35.5 million for the second quarter of 2023, representing a loss per share of $0.13, compared to net loss of $108.5 million , or $0.46 per share, for the same period in 2022. The reduction in losses reflects a strategic shift in the…
- [Inovio Pharmaceuticals cash, equivalents $36.7M as of June 30](https://www.ainvest.com/news/inovio-pharmaceuticals-cash-equivalents-36-7m-june-30-2607) — AInvest Wire, Jul 29, 2026
  As of June 30, 2026, Inovio Pharmaceuticals reported holding $36.7 million in cash and cash equivalents[1]. This figure reflects the company’s liquidity position at the end of the second quarter and may be relevant to investors assessing the firm’s financial flexibility and operational capacity.…
- [Inovio to offer shares of common stock, accompanying warranties](https://www.ainvest.com/news/inovio-offer-shares-common-stock-accompanying-warranties-2607) — AInvest Wire, Jul 29, 2026
  INOVIO Pharmaceuticals, Inc. (Nasdaq: INO) announced on April 1, 2026, its intention to conduct an underwritten public offering of shares of its common stock, along with accompanying Series A and Series B warrants to purchase additional shares of common stock. The offering, which is subject to…

## Similar Stocks

- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).